MCC
ACOR

Malaga Cove Capital’s Acorda Therapeutics ACOR Stock Holding History

Malaga Cove Capital’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-442
Closed -$1.03M – 184
2018
Q3 		$1.03M Buy
442
+7
+2% +$21.7K 0.56% 55
2018
Q2 		$1.5M Sell
435
-17
-4% -$52.1K 0.76% 39
2018
Q1 		$1.28M Buy
452
+58
+15% +$174K 0.69% 47
2017
Q4 		$1.01M Sell
394
-68
-15% -$193K 0.57% 57
2017
Q3 		$1.41M Hold
462
– – 0.81% 40
2017
Q2 		$1.09M Buy
462
+37
+9% +$73.3K 0.65% 49
2017
Q1 		$939K Hold
425
– – 0.57% 58
2016
Q4 		$971K Sell
425
-21
-5% -$49.9K 0.63% 51
2016
Q3 		$1.12M Buy
+446
New +$1.33M 0.81% 42

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Malaga Cove Capital's ACOR Position: Q4 2018 in Review

Malaga Cove Capital sold out of Acorda Therapeutics (ACOR) in Q4 2018, closing a stake of 442 shares — an estimated $1.03M sold.

Malaga Cove Capital first reported a position in ACOR in Q3 2016 and held it in 9 quarters. The position peaked at $1.5M in Q2 2018. 179 funds tracked by Wall St. Rank hold ACOR as of Q4 2018.

  • Malaga Cove Capital reported no remaining Acorda Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Malaga Cove Capital sold 442 Acorda Therapeutics shares in Q4 2018, an estimated $1.03M.
  • Malaga Cove Capital first reported a position in Acorda Therapeutics in Q3 2016 and held it in 9 quarters.
  • Malaga Cove Capital's Acorda Therapeutics position peaked at $1.5M in Q2 2018.
  • 179 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2018.

Based on Malaga Cove Capital's 13F filing for Q4 2018, filed 4 Feb 2019.